Search results
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 7 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 7 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via AOL· 7 days agoThe approval was granted under a breakthrough therapy designation and marks the second approved mRNA...
FDA Green-Lights Moderna Vaccine for Older Adults | Newswise
Newswise· 1 day agoAccording to a company press release, this marks the second approved mRNA product from Moderna and is the only pre-filled syringe available. This approval is also the first ...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 7 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga· 7 days agoThe approval was granted under a breakthrough therapy designation and marks the second approved mRNA product from Moderna, the first being the famed COVID
Tests to begin for COVID treatment developed in South Carolina
News 12 Augusta· 22 hours agoState lawmakers approved millions of dollars for research on a new COVID-19 treatment that will soon...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KOMU Columbia· 6 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Novavax's stock surges almost 300% in the past month
AOL· 23 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...